Angiodynamics (ANGO) Liabilities and Shareholders Equity (2011 - 2026)
Angiodynamics (ANGO) recorded Liabilities and Shareholders Equity of $267.16 million in fiscal Q4 2026 (quarter ended May 31, 2026), down 4.6% from $280.14 million a year earlier but up 2.5% from the prior quarter.
Powered by 
Analysis
Angiodynamics (ANGO) Liabilities and Shareholders Equity (2011 - 2026) Analysis & Trends
Starting with fiscal Q4 2011, Angiodynamics' Liabilities and Shareholders Equity history includes 59 quarters.
- Annual Liabilities and Shareholders Equity has declined for seven straight fiscal years, with a five-year compound annual growth rate of -13.8% (FY2021 to FY2026).
- Across earlier fiscal years, Liabilities and Shareholders Equity came in at $280.14 million in FY2025 (-11.8%), $317.67 million in FY2024 (-40.4%), $532.64 million in FY2023 (-3.6%) and $552.75 million in FY2022 (-1.5%).
- Quarterly Liabilities and Shareholders Equity has ranged from $260.68 million in fiscal Q3 2026 to $558.21 million in fiscal Q2 2023 over the past five years.
- On a year-over-year basis, Liabilities and Shareholders Equity has declined for 14 consecutive quarters, with an average decline of 17.1% over the last eight quarters.
- Peak year-over-year performance for Liabilities and Shareholders Equity in the last five years was growth of 0.7% in fiscal Q2 2023, against a decline of 41.6% in fiscal Q2 2025 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $260.68 million (Q3 2026), $269.68 million (Q2 2026) and $265.64 million (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 249.71 Bn | 228.86 Bn | 4.88 Bn | 113.17 Bn |
| 2 | Abbott Laboratories | 171.00 Bn | 142.08 Bn | 7.27 Bn | 109.22 Bn |
| 3 | Danaher | 155.79 Bn | 139.61 Bn | 3.61 Bn | 92.37 Bn |
| 4 | Intuitive Surgical | 143.91 Bn | 123.46 Bn | 1.96 Bn | 20.88 Bn |
| 5 | Medtronic | 110.42 Bn | 76.29 Bn | 6.34 Bn | 93.31 Bn |
| 6 | Stryker | 105.71 Bn | 91.82 Bn | 4.50 Bn | 47.93 Bn |
| 7 | Boston Scientific | 63.26 Bn | 58.27 Bn | 3.85 Bn | 45.22 Bn |
| 8 | Edwards Lifesciences | 49.80 Bn | 33.91 Bn | 1.35 Bn | 13.87 Bn |
| 9 | Becton Dickinson | 48.78 Bn | 45.93 Bn | 2.32 Bn | 50.73 Bn |
| 10 | Angiodynamics | 641.35 Mn | 469.28 Mn | 46.77 Mn | 267.16 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | 267.16 Mn |
| Feb 28, 2026 | 260.68 Mn |
| Nov 30, 2025 | 269.68 Mn |
| Aug 31, 2025 | 265.64 Mn |
| May 31, 2025 | 280.14 Mn |
| Feb 28, 2025 | 285.42 Mn |
| Nov 30, 2024 | 291.60 Mn |
| Aug 31, 2024 | 293.63 Mn |
| May 31, 2024 | 317.67 Mn |
| Feb 29, 2024 | 324.84 Mn |
| Nov 30, 2023 | 499.62 Mn |
| Aug 31, 2023 | 493.95 Mn |
| May 31, 2023 | 532.64 Mn |
| Feb 28, 2023 | 542.85 Mn |
| Nov 30, 2022 | 558.21 Mn |
| Aug 31, 2022 | 557.70 Mn |
| May 31, 2022 | 552.75 Mn |
| Feb 28, 2022 | 543.18 Mn |
| Nov 30, 2021 | 554.10 Mn |
| Aug 31, 2021 | 555.76 Mn |
API Access
Angiodynamics Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=ANGO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "ANGO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=ANGO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();